ArticleScientific reports2026

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.

Kosuke Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.